Who is sponsoring NCT04962516?

NCT04962516 is sponsored by Peking University Third Hospital.

What drugs are being tested in NCT04962516?

Interventions in NCT04962516: single-use precision filtered infusion sets, single-use precision filter infusion set with needle.

What condition does NCT04962516 study?

NCT04962516 studies Single-use Precision Filter Infusion Set.

Is NCT04962516 still recruiting?

NCT04962516 is currently completed. Last updated 15 July 2021.

Last reviewed 2021-07-15 · How we verify

NCT04962516

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of the Safety and Efficacy of Single-use Precision Filtered Infusion Sets for Intravenous Infusion

Completed Last updated 15 July 2021

What this trial tests

trial testing single-use precision filtered infusion sets in Single-use Precision Filter Infusion Set in 168 participants. Completed in 1 July 2019.

Timeline

1 July 2018

Primary endpoint
1 December 2018

1 July 2019

Quick facts

Lead sponsor	Peking University Third Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	168
Start date	1 July 2018
Primary completion	1 December 2018
Estimated completion	1 July 2019
Sites	2 locations across China

Drugs / interventions tested

single-use precision filtered infusion sets
single-use precision filter infusion set with needle

Conditions studied

Single-use Precision Filter Infusion Set — all drugs for Single-use Precision Filter Infusion Set →

Sponsor

Peking University Third Hospital

Who can join

18 and older, any sex, with Single-use Precision Filter Infusion Set. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a pre-market clinical trial of a single-use precision filter infusion set for pumps, to evaluate the safety and effectiveness of a single-use precision filter infusion set for pumps after being used in humans, and to provide clinical evidence for the official application of the product in China

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Peking University Third Hospital trials

Trials by the same sponsor.

NCT07532421 — Probiotic Intervention on the Development of Allergic Diseases in Infants Exposed to Antibiotics Early in Life · NA · not yet recruiting
NCT07470255 — Detection of Diabetic Foot Skin Damage Using Plantar Mechanical Parameters · not yet recruiting
NCT07453381 — Multisensor Wireless Pressure Microcatheter For Microvascular Function Assessment In ANOCA/INOCA Patients: A Prospective · not yet recruiting
NCT07452354 — AI-Based Diabetic Foot Recurrence Cohort · not yet recruiting
NCT07423819 — Sports Rehabilitation Therapy for Knee Joint Sports Injuries: A Case Study of Anterior Cruciate Ligament Injury and Pate · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04962516 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Peking University Third Hospital
Last refreshed: 15 July 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04962516.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing